No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.

Spoelstra-de Man, A M E; Teerlink, T; Brouwer, C B; Rauwerda, J A; Stehouwer, C D A; Smulders, Y M

Spoelstra-de Man, A M E; Teerlink, T; Brouwer, C B; Rauwerda, J A; Stehouwer, C D A; Smulders, Y M.

Affiliation

Spoelstra-de Man AM; Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.

Clin Endocrinol (Oxf) ; 64(5): 495-501, 2006 May.

Article in En | MEDLINE | ID: mdl-16649966

Subject(s)

Arginine/analogs & derivatives; Cardiovascular Diseases/prevention & control; Folic Acid/therapeutic use; Hyperhomocysteinemia/drug therapy; Pyridoxine/therapeutic use; Vitamin B Complex/therapeutic use; Adolescent; Adult; Arginine/blood; Atherosclerosis/blood; Atherosclerosis/drug therapy; Cardiovascular Diseases/blood; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperhomocysteinemia/blood; Linear Models; Male; Middle Aged; Risk Factors; Time Factors; Treatment Failure

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Pyridoxine / Vitamin B Complex / Cardiovascular Diseases / Hyperhomocysteinemia / Folic Acid Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2006 Document type: Article Affiliation country: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links